Synthomer: Sale of the acrylate trade to Mutares

Share:

The British specialty chemicals group Synthomer is selling its acrylate business to the German investment group Mutares.

Both companies announced the signing of a corresponding agreement at the end of June. No information was given on the financial volume or further details of the deal. The transaction is scheduled to close by the end of the third quarter of this year.

With the Acrylate division, Mutares from Synthomer takes over the Czech subsidiary Synthomer a.s., which produces acrylate monomers and acrylic acid at the Sokolov site near Karlovy Vary. The company, which was previously part of the Synthomer "Health & Protection and Performance Materials" division, employs around 300 people and, according to Mutares, had a stake of around 110 million in the 2025 financial year. EUR around.

As part of its research strategy adopted in autumn 2022, Synthomer is separating from divisions that are not part of its core business. In recent years, i. The compound division to the Belgian sector company Matco (see plasticker news from April 24, 2024) and the laminate and film business to the German Surteco Group (see plasticker news from March 13, 2023).

to the Munich-based Mutares, CIO Johannes Laumann commented: "Synthomer is exactly the kind of opportunity on which our investment strategy is based: a high-condition manufacturing company in a transformation phase with a strong market position and clearly identifiable value enhancers. Together with the regulation team, we look forward to driving the transformation of Synthomer and building a leading platform to acrylate solutions within our Chemicals & Materials segment. to us, this segment stands in particular to development and future substantial exits."

Synthomer mainly produces fluid plastics to dispersions and coatings as well as high-performance elastomers and additives that are applied in various industries. The London-based group employs around 3,800 people at over 30 production sites in Europe, North America and Asia, including in Marl, Germany. to the financial year 2025, Synthomer reports an EBITDA of 136 million. GBP (159 million EUR) from sales of EUR 1.739 billion. GBP (2.029 billion EUR).

Quick inquiry

Create

Inquiry Sent

We will contact you soon